140 related articles for article (PubMed ID: 37955105)
21. Protective effect of vaccinating infants with a 5 µg recombinant yeast-derived hepatitis B vaccine and the need for a booster dose in China.
Miao N; Zheng H; Sun X; Zhang G; Wang F
Sci Rep; 2020 Oct; 10(1):18155. PubMed ID: 33097788
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection.
Fan L; Owusu-Edusei K; Schillie SF; Murphy TV
Hepatology; 2016 May; 63(5):1471-80. PubMed ID: 26509655
[TBL] [Abstract][Full Text] [Related]
23. Postvaccination serologic testing results for infants aged ≤24 months exposed to hepatitis B virus at birth: United States, 2008-2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Sep; 61():768-71. PubMed ID: 23013723
[TBL] [Abstract][Full Text] [Related]
24. Antibody response to postexposure prophylaxis in infants born to hepatitis B surface antigen-positive women.
Euler GL; Copeland JR; Rangel MC; Williams WW
Pediatr Infect Dis J; 2003 Feb; 22(2):123-9. PubMed ID: 12586975
[TBL] [Abstract][Full Text] [Related]
25. Residual risk of mother-to-child transmission of HBV despite timely Hepatitis B vaccination: a major challenge to eliminate hepatitis B infection in Cambodia.
E B; Ko K; Kim R; Nagashima S; Ouoba S; Hussain MRA; Sato T; Chuon C; Abe K; Sugiyama A; Takahashi K; Akita T; Tung R; Ork V; Hossain MS; Saphonn V; Tanaka J
BMC Infect Dis; 2023 Apr; 23(1):261. PubMed ID: 37101167
[TBL] [Abstract][Full Text] [Related]
26. [Sero-epidemiological analysis on hepatitis B among children aged 1-14 years old born to HBsAg positive mother in China, 2014].
Wang FZ; Zheng H; Zhang GM; Miao N; Sun XJ; Cui FQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Apr; 38(4):457-461. PubMed ID: 28468062
[No Abstract] [Full Text] [Related]
27. Progress Toward the Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Worldwide, 2016-2021.
Khetsuriani N; Lesi O; Desai S; Armstrong PA; Tohme RA
MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(30):958-963. PubMed ID: 35900928
[TBL] [Abstract][Full Text] [Related]
28. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].
Yin YZ; Zhou J; Zhang PZ; Hou HY
Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):105-10. PubMed ID: 23663881
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017.
Ork V; Woodring J; Shafiqul Hossain M; Wasley A; Nagashima S; Yamamoto C; Chuon C; Sugiyama A; Ohisa M; Akita T; Ko K; Mao B; Tanaka J
Vaccine; 2019 Aug; 37(35):5059-5066. PubMed ID: 31285088
[TBL] [Abstract][Full Text] [Related]
30. Increased Protection of Earlier Use of Immunoprophylaxis in Preventing Perinatal Transmission of Hepatitis B Virus.
Huang H; Xu C; Liu L; Chen L; Zhu X; Chen J; Feng J; Chen T; Xu B; Yang J; Xu B; Pan M; Dai Y; Hu Y; Zhou YH
Clin Infect Dis; 2021 Nov; 73(9):e3317-e3323. PubMed ID: 32634824
[TBL] [Abstract][Full Text] [Related]
31. Antenatal hepatitis B virus sero-prevalence, risk factors, pregnancy outcomes and vertical transmission rate within 24 months after birth in a high HIV prevalence setting.
Duri K; Munjoma PT; Mataramvura H; Mazhandu AJ; Chandiwana P; Marere T; Gumbo FZ; Mazengera LR
BMC Infect Dis; 2023 Oct; 23(1):736. PubMed ID: 37891471
[TBL] [Abstract][Full Text] [Related]
32. Risk factors associated with immunoprophylaxis failure against mother to child transmission of hepatitis B virus and hepatitis B vaccination status in Yunnan province, China.
Kang W; Ding Z; Shen L; Zhao Z; Huang G; Zhang J; Xiong Q; Zhang S; Zhang S; Wang F
Vaccine; 2014 Jun; 32(27):3362-6. PubMed ID: 24793939
[TBL] [Abstract][Full Text] [Related]
33. Progress Toward Hepatitis B Control - World Health Organization European Region, 2016-2019.
Khetsuriani N; Mosina L; Van Damme P; Mozalevskis A; Datta S; Tohme RA
MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(30):1029-1035. PubMed ID: 34324482
[TBL] [Abstract][Full Text] [Related]
34. A study of immunoprophylaxis failure and risk factors of hepatitis B virus mother-to-infant transmission.
Zhang L; Gui X; Wang B; Ji H; Yisilafu R; Li F; Zhou Y; Zhang L; Zhang H; Liu X
Eur J Pediatr; 2014 Sep; 173(9):1161-8. PubMed ID: 24699981
[TBL] [Abstract][Full Text] [Related]
35. The effectiveness of 20 μg hepatitis B vaccine used for the prevention of HBV vertical transmission.
Yonghao G; Yanping C; Qiaohua D; Daxing F; Yanyang Z; Dongyang Z; Wanshen G
Sci Rep; 2022 Jul; 12(1):11759. PubMed ID: 35817837
[TBL] [Abstract][Full Text] [Related]
36. Reduction of the occurrence of occult HBV infection in infants by increasing the dose of hepatitis B vaccine: a large prospective cohort study.
Li AY; Liu Z; Song Y; Xiao Y; Jiang J; Li L; Zhai X; Liu J; Duan Z; Ding F; Liu J; Zhuang H; Zhu L; Jiang J; Zou H; Wang J; Li J
Emerg Microbes Infect; 2020 Dec; 9(1):1881-1891. PubMed ID: 32779526
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of infants born to women infected with hepatitis B.
Schillie S; Walker T; Veselsky S; Crowley S; Dusek C; Lazaroff J; Morris SA; Onye K; Ko S; Fenlon N; Nelson NP; Murphy TV
Pediatrics; 2015 May; 135(5):e1141-7. PubMed ID: 25896839
[TBL] [Abstract][Full Text] [Related]
38. Applicability and efficacy of a model for prevention of perinatal transmission of hepatitis B virus infection: single center study in Egypt.
El-Karaksy HM; Mohsen LM; Saleh DA; Hamdy MS; Yassin NA; Farouk M; Salit ME; El-Shabrawi MH
World J Gastroenterol; 2014 Dec; 20(45):17075-83. PubMed ID: 25493019
[TBL] [Abstract][Full Text] [Related]
39. Low Level of Hepatitis B Virus Infection in Children 20 Years After Initiation of Infant Vaccination Program in Wallis and Futuna.
Pezzoli L; Mathelin JP; Hennessey K; Eswara-Aratchige P; Valiakolleri J; Kim SH
Am J Trop Med Hyg; 2017 Mar; 96(3):715-719. PubMed ID: 28070010
[TBL] [Abstract][Full Text] [Related]
40. Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study.
Shimakawa Y; Veillon P; Birguel J; Pivert A; Sauvage V; Guillou-Guillemette HL; Roger S; Njouom R; Ducancelle A; Amta P; Huraux JM; Adoukara JP; Lunel-Fabiani F
Lancet Glob Health; 2022 Apr; 10(4):e521-e529. PubMed ID: 35183302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
